Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis
Raphaëlle Bourgeois(Institut universitaire de cardiologie et de pneumologie de Québec), Benoît J. Arsenault(Emory University), Philippe Pîbarot(Emory University), Jakie Guertin(Institut universitaire de cardiologie et de pneumologie de Québec), Nicolas Perrot(Population Health Research Institute), Marlys L. Koschinsky(Western University), Audrey-Anne Després(Institut universitaire de cardiologie et de pneumologie de Québec), Patricia L. Mitchell(Institut universitaire de cardiologie et de pneumologie de Québec), Marie‐Chloé Boulanger(Institut universitaire de cardiologie et de pneumologie de Québec), Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec), Patrick Couture(Université Laval), Corey A. Scipione(Valve (United States)), Romain Devillers(Institut universitaire de cardiologie et de pneumologie de Québec), Michael B. Boffa(Western University)
Cited by 26
Related Papers
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
|The Lancet|2016|1k
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2020|832